Cargando…
Post hoc analysis of the glutamics–trial: intravenous glutamate infusion and use of inotropic drugs after cabg
BACKGROUND: Intravenous glutamate reduced the risk of developing severe circulatory failure after isolated coronary artery bypass graft surgery (CABG) for acute coronary syndrome (ACS) in a double-blind randomised clinical trial (GLUTAMICS-ClinicalTrials.gov Identifier:NCT00489827). Here our aim was...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4971701/ https://www.ncbi.nlm.nih.gov/pubmed/27484576 http://dx.doi.org/10.1186/s12871-016-0216-z |